Wang Ouchen

1 clinical trials · Sponsor

Record	Firm	Date
A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrotinib in the Treatment of Local-advanced HER2-positive Breast Cancer (NCT06234137)	Wang Ouchen	2021-11-27

Every clearance here is in the API, with alerts when new ones post.